Dietary Interventions to Reduce Ultra-Processed Food Intake
Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-70
SponsorOregon Research Institute
About this trial
The DISRUPT clinical trial will test two different 2-month programs to help adults with overweight/obesity (N=60) reduce their intake of ultra-processed foods (UPFs). Participants will be randomly assigned to receive standard dietary change strategies, cognitive dissonance strategies that engage them in activism against the UPF industry, or both. All participants will attend an introductory educational workshop about UPFs. If they are assigned to receive one or more of these strategies, they will attend weekly group sessions with the relevant intervention content for 7 more weeks. Groups will be held virtually.
Eligibility criteria
Qualifiers
Ages 18-70 years old
BMI >25 and <50 kg/m2
Wish to reduce their UPF intake
Consume at least 2 UPF items per day and at least 4 distinct UPF items per week
Disqualifiers
Have ever been diagnosed with anorexia nervosa or bulimia nervosa
Are using medications known to influence eating behavior and/or weight (e.g., semaglutide)
Currently using insulin
History of bariatric surgery
Trial design
Treatments tested in this trial
- Introductory Educational Workshop
- Standard Dietary Change (ON/OFF)
- Cognitive Dissonance Strategies (ON/OFF)
Treatment groups
60 Participants
are divided into 4 treatment groupsLocations
Sponsors and collaborators
Oregon Research Institute
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Albert Einstein College of Medicine
Collaborator
Source ClinicalTrials.gov